Abstract Body

HIV associated neurocognitive disorders (HAND) cause significant morbidity and mortality despite the advent of highly active antiretroviral therapy. A deeper understanding of fundamental molecular mechanisms underlying HIV neuropathogenesis in the central nervous system (CNS) will require relevant model systems. Microglia are resident myeloid cells of the brain that are readily infected by HIV and are likely to contribute to HAND. The purpose of this study was to define the most relevant microglial model systems for those working on HIV infection, replication, and pathogenesis in the CNS.

We evaluated two microglial model cell lines (C20, HMC3) and two sources of primary cell-derived microglia (monocyte-derived microglia [MMG] and induced pluripotent stem cell-derived microglia [iPSC-MG]) as model systems for studying HIV-microglia interactions. Cells were evaluated for relevant marker expression by flow cytometry and immunofluorescence microscopy. Gene expression analysis was performed and results compared between model systems and published microglial datasets.

All four microglial model cells expressed typical myeloid and microglia-specific markers. Significant differences were observed upon gene expression profiling, however. MMG and iPSC-MG clustered closely with primary human microglial cells, while C20 and HMC3 exhibited marked differences. iPSC-MG and MMG expressed HIV-related genes in a manner closely resembling primary microglia. iPSC-MG and MMG were readily infected with R5-tropic HIV, while C20 and HMC3 required pseudotyping for infection. HIV replication dynamics and HIV-1 particle capture by Siglec-1 differed noticeably between MMG and iPSC-MG. In order to study HIV neuropathogenesis in a more CNS representative system, these findings are being extended to a three-dimensional (3D) iPSC-derived cerebral organoid model incorporating iPSC-MG.

iPSC-MG and MMG were superior to transformed microglia cell lines in their similarity to authentic microglia, expression of HIV-relevant genes, and capacity to support HIV replication.